Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing

被引:34
作者
Truong, Cynthia [1 ]
Schroeder, Lee F. [2 ]
Gaur, Rajiv [1 ]
Anikst, Victoria Emma [1 ]
Komo, Ikuko [3 ]
Watters, Colleen [3 ]
McCalley, Erin [3 ]
Kulik, Carole [3 ]
Pickham, David [3 ]
Lee, Nancy J. [3 ]
Banaei, Niaz [1 ,4 ,5 ]
机构
[1] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
[2] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[3] Stanford Hlth Care, Patient Care Serv, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
[5] Stanford Hlth Care, Clin Microbiol Lab, Stanford, CA 94305 USA
关键词
C difficile; Infection; Colonization; Asymptomatic; Carriage; REAL-TIME PCR; RISK-FACTORS; ENZYME-IMMUNOASSAY; STOOL SAMPLES; INFECTION; COLONIZATION; DIARRHEA; TOXIN; CARRIAGE; ACQUISITION;
D O I
10.1016/j.diagmicrobio.2016.12.014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The Clostridium difficile rate in symptomatic patients represents both those with C difficile infection (CDI) and those with colonization. To predict the extent of CDI overdiagnosis, we compared the asymptomatic colonization rate to the symptomatic positivity rate in hospitalized patients using nucleic acid testing. Methods: Between July 2014 and April 2015, formed stool samples were collected from asymptomatic patients after admission to 3 hospital wards at the Stanford Hospital. Stool samples from symptomatic patients with suspected CDI in the same wards were collected for testing per provider order. The GeneXpert C. difficile tcdB polymerase chain reaction (PCR) assay (Cepheid, Sunnyvale, CA, USA) was performed on all stool samples and PCR cycle threshold was used as a measure of genomic equivalents. Chart review was performed to obtain clinical history and medication exposure. Results: We found an asymptomatic C. difficile carriage rate of 11.8% (43/365) (95% confidence interval [CI], 8.515.1%) and a positivity rate in symptomatic patients of 15.4% (54/351) (95% CI, 11.6-19.2%; P = 0.19). The median PCR cycle thresholds was not significantly different between asymptomatic carriers and symptomatic positives (29.5 versus 27.3; P = 0.07). Among asymptomatic patients, 11.6% (5/43) of carriers and 8.4% (27/322; P = 0.56) of noncarriers subsequently became symptomatic CDI suspects within the same hospitalization. Single and multivariate analysis did not identify any demographic or clinical factors as being significantly associated with C difficile carriage. Conclusions: Asymptomatic C difficile carriage rate was similar to symptomatic positivity rate. This suggests the majority of PCR-positive results in symptomatic patients are likely due to C. difficile colonization. Disease specific biomarkers are needed to accurately diagnose patients with C difficile disease. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:365 / 370
页数:6
相关论文
共 38 条
[1]   Prevalence and Risk Factors for Asymptomatic Clostridium difficile Carriage [J].
Alasmari, Faisal ;
Seiler, Sondra M. ;
Hink, Tiffany ;
Burnham, Carey-Ann D. ;
Dubberke, Erik R. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 (02) :216-222
[2]   Organism burden, toxin concentration, and lactoferrin concentration do not distinguish between clinically significant and nonsignificant diarrhea in patients with Clostridium difficile [J].
Anikst, Victoria Emma ;
Gaur, Rajiv Lochan ;
Schroeder, Lee Frederick ;
Banaei, Niaz .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 84 (04) :343-346
[3]   Toxin Immunoassays and Clostridium difficile Infection [J].
Banaei, Niaz ;
Schroeder, Lee Frederick .
JAMA INTERNAL MEDICINE, 2016, 176 (03) :413-413
[4]  
Banaei N, 2015, NEW ENGL J MED, V372, P2368, DOI 10.1056/NEJMc1505190
[5]   Antibiotic-associated diarrhea [J].
Bartlett, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (05) :334-339
[6]   Screening for carriage and nosocomial acquisition of Clostridium difficile by culture:: a study of 284 admissions of elderly patients to six general hospitals in Wales [J].
Brazier, JS ;
Fitzgerald, TC ;
Hosein, I ;
Cefai, C ;
Looker, N ;
Walker, M ;
Bushell, AC ;
Rooney, P .
JOURNAL OF HOSPITAL INFECTION, 1999, 43 (04) :317-319
[7]   Gut Check: Clostridium difficile Testing and Treatment in the Molecular Testing Era [J].
Buckel, Whitney R. ;
Avdic, Edina ;
Carroll, Karen C. ;
Gunaseelan, Vidhya ;
Hadhazy, Eric ;
Cosgrove, Sara E. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (02) :217-221
[8]   Diagnosis of Clostridium difficile Infection: an Ongoing Conundrum for Clinicians and for Clinical Laboratories [J].
Burnham, Carey-Ann D. ;
Carroll, Karen C. .
CLINICAL MICROBIOLOGY REVIEWS, 2013, 26 (03) :604-630
[9]   PRESENCE OF CLOSTRIDIUM-DIFFICILE AND ANTIBIOTIC AND BETA-LACTAMASE ACTIVITIES IN FECES OF VOLUNTEERS TREATED WITH ORAL CEFIXIME, ORAL CEFPODOXIME PROXETIL, OR PLACEBO [J].
CHACHATY, E ;
DEPITRE, C ;
MARIO, N ;
BOURNEIX, C ;
SAULNIER, P ;
CORTHIER, G ;
ANDREMONT, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) :2009-2013
[10]   ACQUISITION OF CLOSTRIDIUM-DIFFICILE BY HOSPITALIZED-PATIENTS - EVIDENCE FOR COLONIZED NEW ADMISSIONS AS A SOURCE OF INFECTION [J].
CLABOTS, CR ;
JOHNSON, S ;
OLSON, MM ;
PETERSON, LR ;
GERDING, DN .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (03) :561-567